1. Short title This Act may be cited as the Transparent Drug Pricing Act of 2019 . 2. Price transparency at pharmacies Section 1927(g)(2) of the Social Security Act ( 42 U.S.C. 1396r–8(g)(2) ) is amended by adding at the end the following new subparagraph: (E) Disclosure of drug prices at point of sale Beginning January 1, 2022, as part of a State's drug use review program, applicable State law shall require pharmacists to disclose to customers, at the point of sale of any prescription drug— (i) the customer's out-of-pocket cost with respect to acquisition of such drug under the health plan in which the customer is enrolled, if applicable